We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VVX icon
1026
V2X
VVX
$2.6B
$212K 0.02%
+3,880
New +$218K
KPTI icon
1027
Karyopharm Therapeutics
KPTI
$44.4M
$211K 0.02%
+28,723
New +$176K
MNDY icon
1028
monday.com
MNDY
$3.75B
$211K 0.02%
1,430
-4,204
-75% -$708K
NEE icon
1029
NextEra Energy
NEE
$177B
$211K 0.02%
+2,627
New +$218K
PFSI icon
1030
PennyMac Financial
PFSI
$3.94B
$211K 0.02%
+1,598
New +$204K
APTV icon
1031
Aptiv
APTV
$10.3B
$210K 0.02%
+2,766
New +$222K
NKE icon
1032
Nike
NKE
$62.5B
$210K 0.02%
+3,298
New +$215K
VRTX icon
1033
Vertex Pharmaceuticals
VRTX
$133B
$210K 0.02%
+463
New +$200K
ACM icon
1034
Aecom
ACM
$9.42B
$210K 0.02%
+2,201
New +$259K
SILA
1035
DELISTED
Sila Realty Trust
SILA
$210K 0.02%
+9,000
New +$212K
AMAT icon
1036
Applied Materials
AMAT
$415B
$210K 0.02%
816
-871
-52% -$209K
MRNA icon
1037
Moderna
MRNA
$23.9B
$209K 0.02%
+7,095
New +$193K
VEON icon
1038
VEON
VEON
$3.87B
$209K 0.02%
+3,977
New +$201K
GOVT icon
1039
iShares US Treasury Bond ETF
GOVT
$43.6B
$209K 0.02%
+9,070
New +$210K
CVS icon
1040
CVS Health
CVS
$122B
$208K 0.02%
2,623
-14,666
-85% -$1.16M
CSL icon
1041
Carlisle Companies
CSL
$15.3B
$208K 0.02%
+649
New +$210K
CMRC
1042
Commerce.com Inc Series 1
CMRC
$175M
$208K 0.02%
50,381
+6,529
+15% +$30.1K
STAA icon
1043
STAAR Surgical
STAA
$1.25B
$207K 0.02%
8,980
-146,310
-94% -$3.77M
SAIA icon
1044
Saia
SAIA
$9.49B
$207K 0.02%
+635
New +$192K
WAL icon
1045
Western Alliance Bancorporation
WAL
$8.78B
$207K 0.02%
2,463
-1,799
-42% -$146K
GRBK icon
1046
Green Brick Partners
GRBK
$3.03B
$207K 0.02%
+3,299
New +$217K
FRT icon
1047
Federal Realty Investment Trust
FRT
$10.2B
$207K 0.02%
+2,050
New +$202K
BX icon
1048
Blackstone
BX
$113B
$207K 0.02%
1,340
-2,049
-60% -$311K
SQM icon
1049
Sociedad Química y Minera de Chile
SQM
$20.8B
$206K 0.02%
+3,000
New +$165K
USFD icon
1050
US Foods
USFD
$23.9B
$206K 0.02%
2,739
-2,770
-50% -$208K
40 41
42
43 44

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.